Tourmaline Bio Inc. (TRML)
16.46
-0.54 (-3.18%)
At close: Jan 28, 2025, 3:59 PM
16.50
0.24%
After-hours Jan 28, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -42.12M | -19.70M | -47.83M | -22.71M | -18.16M |
| Depreciation & Amortization | 33.00K | 6.00K | 623.00K | 447.00K | 379.00K |
| Stock-Based Compensation | 5.77M | 195.00K | n/a | n/a | n/a |
| Other Working Capital | -124.00K | 709.00 | 992.00K | 1.51M | -85.00K |
| Other Non-Cash Items | 8.41M | 12.14M | 4.83M | 2.23M | 959.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -168.00K | 902.00K | 2.31M | 1.61M | -85.00K |
| Operating Cash Flow | -28.08M | -6.46M | -39.99M | -19.21M | -17.66M |
| Capital Expenditures | -56.00K | -5.07M | -2.44M | -1.29M | -562.00K |
| Acquisitions | n/a | -5.00M | n/a | n/a | n/a |
| Purchase of Investments | -16.60M | n/a | -275.88M | -158.24M | n/a |
| Sales Maturities Of Investments | 20.50M | n/a | 181.93M | 26.22M | n/a |
| Other Investing Acitivies | n/a | -5.00K | n/a | n/a | n/a |
| Investing Cash Flow | 3.84M | -5.07M | -96.39M | -133.30M | -562.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 86.25M | 19.85M | -277.00K | n/a | n/a |
| Financial Cash Flow | 156.72M | 19.85M | 137.40M | 131.12M | 36.20M |
| Net Cash Flow | 132.48M | 8.32M | 1.02M | -21.39M | 17.98M |
| Free Cash Flow | -28.14M | -11.53M | -42.42M | -20.50M | -18.22M |